Internal Medicine, Hematology & Oncology · State College, PA
NPI
1689015042
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
235 Wellness Way
State College, PA, 16803
Phone (814) 231-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
219,869 services
Medicare patients, 2024
499
Average age 75
Drug cost, 2024
$4.5M
2,070 prescriptions
Company payments, 2025
$673
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aderonke Ajala was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 27,030 times for 34 patients. In total Aderonke Ajala billed 219,869 services in 134 codes, and Medicare paid $3.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 27,030 | 34 | $0.28 | $7,450 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,800 | 18 | $44.63 | $884K |
| J1756 Injection, iron sucrose, 1 mg | Office | 12,000 | 16 | $0.17 | $2,029 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,650 | 27 | $0.11 | $1,215 |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,096 | 13 | $0.08 | $495 |
| J0897 Injection, denosumab, 1 mg | Office | 6,060 | 23 | $20.84 | $126K |
| J0185 Injection, aprepitant, 1 mg | Office | 3,510 | 11 | $1.38 | $4,857 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,900 | 14 | $2.20 | $4,186 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,590 | 11 | $24.78 | $39K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,434 | 33 | $0.09 | $129 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,160 | 37 | $0.69 | $798 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 468 | 16 | $49.21 | $23K |
| 96413 Chemotherapy Administration | Office | 441 | 100 | $99.84 | $44K |
| 96401 Chemotherapy Administration | Office | 364 | 16 | $56.40 | $21K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 356 | 12 | $0.23 | $83.09 |
By year: 2022 $2.6M for 145,933 services; 2023 $2.0M for 142,751 services; 2024 $3.4M for 219,869 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aderonke Ajala prescribed most often to Medicare patients was Anastrozole, with 262 prescriptions and refills. In total Aderonke Ajala wrote 2,070 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 262 | 625 | 75 | $6,347 |
| Prednisone Generic | 192 | 201 | 42 | $589 |
| Tamoxifen Citrate Generic | 126 | 257 | 27 | $3,467 |
| Eliquis Apixaban | 103 | 127 | 20 | $73K |
| Abiraterone Acetate Generic | 101 | 101 | 18 | $272K |
| Oxycodone Hcl Generic | 84 | 85 | 33 | $1,861 |
| Ondansetron Hcl Generic | 68 | 68 | 21 | $443 |
| Dexamethasone Generic | 68 | 76 | 32 | $1,047 |
| Acyclovir Generic | 59 | 67 | 12 | $643 |
| Hydroxyurea Generic | 58 | 114 | 15 | $1,426 |
| Gabapentin Generic | 55 | 57 | 15 | $1,078 |
| Pantoprazole Sodium Generic | 41 | 61 | 12 | $454 |
| Ibrance Palbociclib | 37 | 37 | Under 11 | $593K |
| Letrozole Generic | 32 | 82 | 14 | $829 |
| Methylprednisolone Generic | 32 | 32 | 30 | $324 |
Brand drugs: 404 claims; generic drugs: 1,666 claims; opioid claims: 136.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aderonke Ajala $673 ($673 in general payments such as food, travel and fees) from 11 companies. The largest payer was Pfizer Inc. with $189.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $189 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $89.99 |
| Daiichi Sankyo Inc. 4568.T | 3 | $89.4 |
| Aveo Pharmaceuticals, Inc. | 2 | $48.99 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $48.42 |
| Abbvie Inc. ABBV | 2 | $47.71 |
| Astellas Pharma US Inc 4503.T | 2 | $45.98 |
| GlaxoSmithKline, LLC. GSK | 2 | $45.03 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $30.6 |
| Array Biopharma Inc PFE | 2 | $21.94 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.